Mechanisms and direction of allocation bias in randomised clinical trials.

about

Applying a systems approach to thyroid physiology: Looking at the whole with a mitochondrial perspective instead of judging single TSH values or why we should know more about mitochondria to understand metabolism.

P2860

Q33561107-E25DC19C-7AAE-4B73-9752-8D10BF15EE79

P2860

Mechanisms and direction of allocation bias in randomised clinical trials.

Item

http://www.wikidata.org/entity/Q36157943

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Mechanisms and direction of allocation bias in randomised clinical trials.

@ast

Mechanisms and direction of allocation bias in randomised clinical trials.

@en

type

Item

label

Mechanisms and direction of allocation bias in randomised clinical trials.

@ast

Mechanisms and direction of allocation bias in randomised clinical trials.

@en

prefLabel

Mechanisms and direction of allocation bias in randomised clinical trials.

@ast

Mechanisms and direction of allocation bias in randomised clinical trials.

@en

P1476

Mechanisms and direction of allocation bias in randomised clinical trials.

@en

P2093

Asger Paludan-Müller

http://www.w3.org/2001/XMLSchema#string

P2860

Randomisation to protect against selection bias in healthcare trials

Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

STREPTOMYCIN treatment of pulmonary tuberculosis

Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

Systematic reviews in health care: Assessing the quality of controlled clinical trials

Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials.

Statistics notes. Treatment allocation in controlled trials: why randomise?

Understanding controlled trials. Randomisation methods: concealment

P2888

s12874-016-0235-y

P304

133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12874-016-0235-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Asbjørn Hróbjartsson

David Ruben Teindl Laursen

P577

2016-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1044485840

http://www.w3.org/2001/XMLSchema#string

P698

27717321

http://www.w3.org/2001/XMLSchema#string

P921

bias

P932

5055724

http://www.w3.org/2001/XMLSchema#string

Mechanisms and direction of allocation bias in randomised clinical trials.

about

P2860

P2860

Mechanisms and direction of allocation bias in randomised clinical trials.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932